Use of Gender, Age, Alfa-fetoprotein (AFP), and Des-gamma-carboxyprothrombin (PIVKA-II) or GAAD Score in Addition to Ultrasound for Surveillance of People At-risk for Developing Hepatocellular Carcinoma in Asia in Order to Detect Early Liver Cancer

Clinical trial NCT07298577 · ENROLLING_BY_INVITATION

Trial details

NCT number: NCT07298577
Sponsor: Siriraj Hospital
Status: ENROLLING_BY_INVITATION
Phase: Not Applicable
Study type: INTERVENTIONAL

Liver Cirrhosis Hepatitis B, Chronic Hepatitis C, Chronic Carcinoma, Hepatocellular

Start date: 2026-02-02
Primary completion: 2029-02-02
Enrollment: 2100

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.